期刊文献+

晚期氧化蛋白产物导致血管内皮细胞氧化应激损伤 被引量:20

Advanced oxidation protein products induce oxidative stress in human endothelial cells
下载PDF
导出
摘要 目的 研究慢性肾功能衰竭病人循环晚期氧化蛋白产物 (AOPP)对人血管内皮细胞活性的影响及机制。方法 用次氯酸(HOCl)氧化牛血清白蛋白 (BSA)体外制备AOPP BSA ,将人血管内皮细胞株ECV30 4与不同浓度、不同氧化修饰程度的AOPP BSA共同培养 ,用MTT法测定细胞活性 ,用VICTORWallac 14 2 0多标记分析系统动态检测细胞内活性氧的产生量。结果 AOPP BSA使血管内皮细胞活性降低 ,其对内皮细胞活性的影响与BSA氧化程度及AOPP BSA的浓度有关 ;AOPP BSA刺激内皮细胞生成活性氧 ,细胞内活性氧的生成量随BSA氧化程度和AOPP BSA浓度增加而升高。用硒谷胱甘肽过氧化物酶小分子模拟物ebselen预处理细胞 ,可使AOPP BSA诱导产生的活性氧减少 5 3% ,并可保护细胞免受AOPP BSA造成的细胞损伤。结论 晚期氧化蛋白产物能通过氧化应激引起血管内皮细胞损伤。 Objective A close relationship between atherosclerosis and plasma levels of advanced oxidation protein products (AOPP) has been demonstrated in patients with chronic renal failure. The present study was performed to investigate the effect of AOPP on human endothelial cells. Methods Human umbilical vein endothelial cell line ECV304 was incubated with different concentrations of AOPP-BSA, which prepared by combining BSA with HOCl at different molar ratios. Cell viability was measured by MTT assay. Intracellular production of reactive oxygen species (ROS) was evaluated kinetically using VICTOR Wallac 1420 mutilabel counter. Results AOPP-BSA decreased endothelial cell viability, which was dependent on the molar ratio of BSA/HOCl and the concentration of AOPP-BSA. AOPP-BSA also enhanced the intracellular ROS production in ECV304. AOPP-induced ROS production was correlated with the molar ratio of BSA/HOCl and the concentration of AOPP-BSA. Pretreatment of cells with a small molecular glutathione peroxidase mimic (ebselen) reduced AOPP-induced ROS production by 53% with preservation of cell viability. Conclusion AOPP decreased endothelial cell viability via induction of oxidative stress.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2004年第11期951-954,共4页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金重点项目(编号 30 330 30 0 ) 广东省团队项目 (编号 1 0 71 7)资助课题
关键词 晚期氧化蛋白产物 内皮 血管 活性氧组分 氧化性应激 advanced oxidation protein products endothelium, vascular reactive oxygen species oxidative stress
  • 相关文献

参考文献17

  • 1[1]Witko-Sarsat V, Friedlander M, Capeillere-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int, 1996, 49(5):1304
  • 2[2]Witko-Sarsat V, Friedlander M, Nguyen AT et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol,1998, 161(5):2524
  • 3[3]Witko-Sarsat V, Gausson V, Nguyen AT et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int, 2003, 64(1):82
  • 4[4]Kaneda H, Taguchi J, Ogasawara K et al. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis, 2002, 162(1):221
  • 5[5]Drueke T, Witko-Sarsat V, Massy Z et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation, 2002, 106(17):2212
  • 6郭志坚,侯凡凡,刘尚喜,张卫茹,周展眉,刘志强.糖化和氧化产物修饰的蛋白质促进兔主动脉粥样斑块形成[J].北京大学学报(医学版),2004,36(2):127-130. 被引量:16
  • 7[7]Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods, 1989, 119(2):203
  • 8[8]Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol, 1994, 55(2):253
  • 9[9]SX, Chen Y, Zhou M et al. Inhibitory effect of ebselen on the oxidation of low density lipoprotein. Redox Report, 1995,1:357
  • 10[10]Jungers P, Massy ZA, Khoa TN et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant, 1997,12(12):2597

二级参考文献17

  • 1Kalousova M,Zima T,Tesar V,et al.Advanced glycation end products and advanced oxidation protein products in hemodialyzed patients[J].Blood Purif,2002,20:531 - 536
  • 2Hou FF,Owen WF.Beta 2-microglobulin amyloidosis:role of monocytes/macrophages[J].Curr Opin Nephrol Hypertens,2002,11:417 -421
  • 3Witko-Sarsat V,Gausson V,Nguyen AT,et al.AOPP-induced activation of human neutrophil and monocyte oxidative metabolism:a potential target for N-acetylcysteine treatment in dialysis patients [J].Kidney Int,2003,64:82 -91
  • 4Kaneda H,Taguchi J,Ogasawara K,et al.Increased level of advanced oxidation protein products in patients with coronary artery disease[J].Atherosclerosis,2002,162:221 -225
  • 5Hou FF,Boyce J,Chertow GM,et al.Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin [J].J Am Soc Nephrol,1998,9:277 -283
  • 6Witko-Sarsat V,Friedlander M,Nguyen KT,et al.Advanced oxida-tion protein products as novel mediators of inflammation and monocyteactivation in chronic renal failure[J].J Immunol,1998,161:2524- 2532
  • 7Lehr HA,Sagban TA,Ihling C,et al.Immunopathogenesis of ather-osclerosis:endotoxin accelerates atherosclerosis in rabbits on hyper-cholesterolemic diet[J].Circulation,2001,104:914 -920
  • 8Witko-Sarsat V,Friedlander M,Capeillere-Blandin C,et al.Advanced oxidation protein products as a novel marker of oxidative stress in uremia[J].Kidney Int,1996,49:1304 - 1313
  • 9Hou FF,Miyata T,Boyce J,et al.Beta(2) -Microglobulin modified with advanced glycation end products delays monocyte apoptosis [J].Kidney Int,2001,59:990 - 1002
  • 10Ross R.Atherosclerosis--an inflammatory disease [J].N Engl J Med,1999,340:115 - 126

共引文献36

同被引文献226

引证文献20

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部